Regulation Of T Cell Effector Function In Peripheral Tissues
Funder
National Health and Medical Research Council
Funding Amount
$698,550.00
Summary
Protection from infections relies on different types of immune cells. While some of these cells are found in the blood, others reside in peripheral tissues such as the skin. We will analyse the function of these peripheral immune cells to understand how they work to fight off infections. We will also investigate how so-called memory cells that permanently reside in peripheral tissues can protect from re-infection with similar bacteria or viruses.
Molecular And Cellular Control Of Human Th9 Cell Differentiation In Health And Disease
Funder
National Health and Medical Research Council
Funding Amount
$550,888.00
Summary
T helper 9 (Th9) cells are a recently defined population of CD4+ T cells that have been implicated in immunological disorders ranging from allergy, asthma, inflammatory bowel disease, and cancer, to host defence against fungal and parasitic infections. As such, Th9 cells are extremely important to human health and disease. This project aims to define the mechanisms involved in the generation, regulation and function of human Th9 cells.
The Mezzanine T Cell Response: Intervening At The Coal Face
Funder
National Health and Medical Research Council
Funding Amount
$765,585.00
Summary
In an initial immune response, specialised cells in lymph nodes tell T cells to multiply; the stimulated T cells depart and enter target tissue (e.g. lung in the case of flu). We describe a new response whereby the target tissue itself can tell T cells to multiply further. This response in target tissues reveals a new way of altering immune responses. This is especially important as in many diseases, the primary lymph node response has already occurred, so cannot be therapeutically intervened.
The Role Of Kdm1a In Epigenetic Regulation Of Virus-specific T Cell Differentiation.
Funder
National Health and Medical Research Council
Funding Amount
$510,982.00
Summary
Recovery from infection, or vaccination, results in the establishment of protective immunity that persists for the life of an individual. Unfortunately, our understanding of how protective immunity is established and maintained after infection or vaccination is lacking. This proposal will determine whether specific enzymes involved in rewriting the genetic blueprint are key for establishing and maintaining this protective capacity. Understanding these mechanisms has implications for vaccination ....Recovery from infection, or vaccination, results in the establishment of protective immunity that persists for the life of an individual. Unfortunately, our understanding of how protective immunity is established and maintained after infection or vaccination is lacking. This proposal will determine whether specific enzymes involved in rewriting the genetic blueprint are key for establishing and maintaining this protective capacity. Understanding these mechanisms has implications for vaccination and improved immunotherapy strategies for cancer.Read moreRead less
Determinants Of CTL Recruitment Into The Immune Response
Funder
National Health and Medical Research Council
Funding Amount
$474,647.00
Summary
The size of CD8+ T cell (CTL) responses is central to their efficacy in virus control, and can be substantially influenced by how effectively they are recruited and expand after infection. This study will determine the impact of both CTL characteristics and antigen abundance on CTL recruitment and expansion after infection. Understanding the nature of these influences will enable a more informed approach to the clinical manipulation of CTL responses.
Defining The Role Of Innate T Cells In The Onset And Progression Of Chronic Periodontitis
Funder
National Health and Medical Research Council
Funding Amount
$581,978.00
Summary
Particular immune cell populations (innate T cells), have a critical role in immunity. These cells are stimulated by bacterial cell wall components and are one of the first cells to appear after infection. We have shown that these innate T cells are stimulated by oral bacteria that cause the disease chronic periodontitis. This project will investigate how these innate T cells affect bacterial induced periodontitis and what role they play in disease outcomes.
The Impact Of Micropolymorphism Within The T Cell Receptor Genes And Their Target Antigenic Peptides
Funder
National Health and Medical Research Council
Funding Amount
$365,126.00
Summary
T lymphocytes play a pivotal role in the immune system by recognising virus-infected tissue through the use of highly specific T cell receptors (TCRs). This project will investigate the importance of genetic variation in the TCR genes in influencing how we fight infections. Another aim is to examine how the immune system tolerates genetic variation in an infecting virus. Advances in these areas will aid in the development of new "intelligent" vaccines.
THE ROLE OF TUMOUR-EGRESSING T CELLS IN ANTI-TUMOUR IMMUNE RESPONSES
Funder
National Health and Medical Research Council
Funding Amount
$603,333.00
Summary
Immune cells can play both beneficial and detrimental roles in cancer. We have devised a novel method to ‘tag’ immune cells inside tumours and follow their fate. Using this method we discovered that immune cells called T cells can leave primary tumours and migrate to lymph nodes. The aim of this project is to investigate the role of these tumour-egressing cells in tumour immunity and to determine whether their migration and function can be manipulated to improve anti-tumour therapies.
Immune responses to pathogens are generated in lymphoid tissues that are innervated by the sympathetic nervous system, which functions during times of stress or infection. Very little is known about the impact of the sympathetic nervous system on immune cell functions during responses to pathogens. This project will test the hypothesis that nervous signals can influence lymphocyte behaviour and that pharmaceutical intervention could augment immunity to infections.
Working Towards A New Therapy For The Prevention Of Restricted Fetal Growth
Funder
National Health and Medical Research Council
Funding Amount
$711,356.00
Summary
If a baby does not grow properly during pregnancy there can be serious health problems when it is born. We also know that small babies have life long risks of poorer health. We have no effective therapies for improving a baby's growth. This application aims to discover a treatment that can help babies grow. This would be an important advance in improving the health of our future Australians.